Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CYDY - CytoDyn: Far From Failure

CYDY - CytoDyn: Far From Failure

CytoDyn Inc
  • CytoDyn's drug leronlimab (PRO-140) is not a failure.
  • Bears are dismissing the efficacy of the drug by focusing solely on the shortcomings of management.
  • Leronlimab has multiple indications with an excellent safety record and is worth more than the $1.5 billion market cap of the company today.

For further details see:

CytoDyn: Far From Failure
Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...